series-b
Stage
About
Candel Therapeutics is a clinical-stage immuno-oncology company developing oncolytic virus therapies that recruit and activate the immune system to attack cancer.
Explore Candel Therapeutics's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.